Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation
Príomhchruthaitheoirí: | Ziberna, K, Recalde, A, Carnicer, R, Casadei, B |
---|---|
Formáid: | Conference item |
Foilsithe / Cruthaithe: |
Springer Berlin Heidelberg
2016
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
de réir: Mighiu, AS, et al.
Foilsithe / Cruthaithe: (2021) -
Role of diabetes mellitus in atrial fibrillation and potential new treatments
de réir: Ziberna, K
Foilsithe / Cruthaithe: (2020) -
154 Myocardial nox2 activity regulates atrial fibrillation susceptibility
de réir: Mighiu, A, et al.
Foilsithe / Cruthaithe: (2017) -
Compromised redox homeostasis, altered nitroso-redox balance and therapeutic possibilities in atrial fibrillation
de réir: Simon, J, et al.
Foilsithe / Cruthaithe: (2016) -
BH4 supplementation as a new treatment for diabetic cardiomyopathy
de réir: Carnicer, R, et al.
Foilsithe / Cruthaithe: (2019)